Navigation Links
Z Trim Holdings Reports Restatement of Previously Issued Financial Statements; Amends Bylaws
Date:11/1/2007

MUNDELEIN, Ill., Nov. 1 /PRNewswire-FirstCall/ -- Z Trim Holdings, Inc. (Amex: ZTM), reported today that it has filed a Current Report on Form 8-K with the Securities Exchange Commission ("SEC") disclosing that it will restate certain financial statements as a result of a determination by Z Trim that those financial statements should no longer be relied upon. Specifically, the Company determined that its financial statements for the quarters ended March 31, 2007 and June 30, 2007 should no longer be relied upon because of accounting errors in those financial statements relating to specific equity transactions.

Steve Cohen, Z Trim's President, stated, "Restating these financial statements is a positive step toward correcting our current deficiencies with the American Stock Exchange and fulfilling our commitment to our shareholders to improve company performance."

Background of Restatement.

On November 22, 2004, the Company entered into a two-year engagement with David Shemesh and Mordechai Tobian for investor relations services in consideration of 2,250,000 shares of restricted common stock of the Company (the "Shemesh/Tobian Shares") and a warrant to purchase 275,000 shares of restricted common stock at $.80 per share through November 21, 2007. Based on a closing price of the Company's common stock of $.79 on November 22, 2004, the Company recorded paid-in-capital of $1,777,500 as of that date and began to recognize investor relation expenses on a quarterly basis over the life of the two-year contract.

On August 24, 2005, the Company took the position that Shemesh and Tobian had failed to perform as agreed and the Company rescinded the contract. Simultaneously, the Company placed a stop order on
'/>"/>

SOURCE Z Trim Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... CDC urges H1N1 vaccination because pandemic,s cou...ec. 1 (HealthDay News) -- A U.S. health official s...to be on the wane nationally, but many experts agr...ter. , The flu is now widespread in 32 states -...R. Frieden, director of the U.S. Centers for Disea...
(Date:12/1/2009)..., , RESEARCH TRIANGLE PARK, N.C., Dec....re initiated in 2001 and have expanded over the ye...globally. The facility which was originally set up...e. Pharmacy services, as part of the suite of serv...harma industry as a valuable offering. ,, The p...
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-USNewsw.... Agency for International Development: ,, Chai...he Committee. ,, I am honored to be nominated b... United States Agency for International Developmen...he Agency. ,, Secretary of State Clinton has e...
(Date:12/1/2009)..., (December 1, 2009) The ADEAGies Foundation wil...Achievement Award at the Gies Awards celebration t... in conjunction with the 2010 ADEA Annual Session ...n, Innovation, and Achievement recognize contribut...cation initiatives. For a complete listing of Gies...
(Date:12/1/2009)... Stronger cardiovascular system tied to academic a....1 (HealthDay News) -- A strong cardiovascular sys...g for better school grades and more overall succes... that most doctors and laypeople know (or should k...althy bodies, the authors of a new study, appearin...
Breaking Medicine News(10 mins):Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 2Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 3Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 4Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 5Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 6Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 7Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 8Health News:Testimony Before the Senate Committee on Foreign Relations Administrator Designate Dr. Rajiv Shah December 1, 2009 9Health News:The Forsyth Institute receives the William J. Gies Award for outstanding achievement 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3
...ad Public Policy, WASHINGTON, Sept. 27 - A ground...rn Reserve University professors Max,Mehlman and D...some,prohibitively expensive and would come at the...lth courts would require,the creation of new and c...
...evelopment, Highlight, Professional Development O...NCINNATI, Sept. 27 Kendle (Nasdaq: KNDL ), a,lea...zation, today,announced that Vice President, Globa...n Friday, Sept. 28 at 9 a.m. The,presentation, tit...
...ers, and Weiner, ALEXANDRIA, Va., Sept. 27 The N...oday applauds the official launch,of the bipartisa...Coalition,s primary objective is to preserve patie...ide in underserved,rural and urban communities. "...
...n Pharma,Limited, a specialty pharmaceutical compa...etary products in secondary healthcare and related...e marketing and,distribution rights to DepoDur(R) ... http://www.newscom.com/cgi-bin/prnh/20070618/PACI...
...aq: PRGO ; TASE) announced today that it had file...uaifenesin Extended-Release Tablets, 600 mg, a,gen...extended-release tablets, 600 mg), an expectorant,...rs for the 12 months ended August 2007, as measure...
...p Consumers Measure Their ...he creators of,the "Life ... supplemented" campaig...Wells, Wells, WannabeWells or OhWells. With the la...re their,wellness regimen and determine where they...
Other Medicine News:Health News:New Report Says 'Health Courts' Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights 2Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 2Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 3Health News:Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007 4Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 2Health News:Congressional Community Pharmacy Coalition To Protect Community Pharmacies and Preserve Patient Access 3Health News:Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe 2Health News:Flynn Pharma Acquires Rights From Pacira Pharmaceuticals to DepoDur(R), the Only Extended-Release Epidural Opioid for Post-Operative Pain, in Europe 3Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 2Health News:Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory 3Health News:Are You An AlphaWell or An OhWell? 2
(Date:12/1/2009)..., BOTHELL, Wash., Dec. 1 ...hat on November 20, 2009 it licensed to Chrono Nut...facture and sell four extended release dietary sup...delivery platform. In addition, SCOLR granted Chr...ducts in the United States on a nonexclusive basis...
(Date:12/1/2009)...LEN BURNIE, Md., Dec. 1 Sleep Solu...rvice provider for home testing and evaluation of ... named Richard Hassett, M.D., as its chief executi...f Matria Healthcare, during its growth from a $250...llion industry leader in total population health, ...
(Date:12/1/2009)... , TAI,AN, China, Dec. 1 /PRNewswire-Asia...Bulletin Board: CBPO) (Nasdaq: CBPO ) ("China Bio...ma-based biopharmaceutical companies in,China, tod...l to list its,common stock on the NASDAQ Global Ma... to begin trading on the NASDAQ on,Wednesday, Dece...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 1US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 1DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 3DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 4Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 1Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 2
...ence Call to be Held at 9:00 a.m. Eastern Time Tod...United Therapeutics Corporation (Nasdaq: UTHR ) ...ug Administration (FDA) has approved ADCIRCA(TM) (... recommended dose of 40 mg, as the first once-dail...e treatment of pulmonary arterial hypertension (PA...
...LIS, Md., May 22 PharmAthene, Inc. (NYSE Amex: ...ountermeasures against biological and chemical thr...ed its comprehensive regulatory strategy to the U....e non-clinical and clinical development plans for ...inant protective antigen anthrax vaccine. , , The...
Other Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 2PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 3PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 4
Acri.Sil-oI 1000
Ispan SF6 Intraocular Gases
Silikon 1000 Silicone Oil
Foreign body spud
Medicine Products: